# A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of KIT2014 in Patients With Moderate to Severe COPD

> **NCT07668518** · PHASE1,PHASE2 · RECRUITING · sponsor: **Kither Biotech Srl** · enrollment: 36 (estimated)

## Conditions studied

- Chronic Obstructive Pulmonary Disease (COPD)

## Interventions

- **DRUG:** KIT2014
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07668518
- **Lead sponsor:** Kither Biotech Srl
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-05
- **Primary completion:** 2027-03-31
- **Final completion:** 2027-07-31
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2026-09-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07668518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07668518, "A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of KIT2014 in Patients With Moderate to Severe COPD". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07668518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*